Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi:10.1016/j.cmet.2012.08.002 6
Although early combination therapy may increase initial costs, it has the potential to reduce long-term healthcare expenditures by lowering the need for interventions and hospitalizations [127,128]
Greater decreases in postprandial glucose levels were observed with exenatide than with liraglutide or exenatide LAR [17,76]
Glucagon-like peptide-1 (GLP-1) receptor agonists were originally developed to treat diabetes and were found to cause weight loss in patients taking them
US$ 29.69
US$ 27.65
US$ 23.48
US$ 26.03
US$ 29.14
US$ 22.08
